COMBINING THE EXPRESSION LEVELS OF KRT19 AND COL1A2 TO PRODUCE A SCORE FOR SCREENING AND DIAGNOSING CANCER

The present invention provides an epithelial and stromal biomarker combination that is useful in determining whether a subject has a high or low likelihood of a tumor. In particular, the invention provides methods for screening, detecting or monitoring a tumor in a subject, the method comprising com...

Full description

Saved in:
Bibliographic Details
Main Authors Simón Buela, Laureano, Otero Alen, Begoña, Domínguez Hormaetxe, Saioa, Estévez Pérez, Lara Sofía, Concha López, Ángel, Otero Alén, Maria
Format Patent
LanguageEnglish
French
German
Published 12.06.2024
Subjects
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention provides an epithelial and stromal biomarker combination that is useful in determining whether a subject has a high or low likelihood of a tumor. In particular, the invention provides methods for screening, detecting or monitoring a tumor in a subject, the method comprising combining the expression levels of KRT19 and COL1A2 to produce a score and based on that score, determining whether the subject has a high likelihood or low likelihood of a tumor.
Bibliography:Application Number: EP20220383195